Hormonal contraceptives’ safety profile comparison for women with sickle cell disease
A recent study presented at ASH 2022 examined the safety profiles of different hormonal contraceptives for female sickle cell disease patients at risk of thromboembolism.
Lower pregnancy BMI, increased antibiotics may contribute to allergic sensitization
A recent study in Finland finds 2 major contributing factors to allergic disease in infants with familial risk.
2 Clarke Drive Cranbury, NJ 08512